Severe congenital neutropenia
|
phenotype |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
66
|
26
|
0.030 |
None |
1.000 |
3 |
|
2000 |
2017 |
Congenital neutropenia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Congenital Abnormality
|
68
|
11
|
0.030 |
None |
1.000 |
3 |
|
2000 |
2017 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Mammary Tumorigenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
162
|
5
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
53 |
1
|
2001 |
2020 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.030 |
None |
1.000 |
3 |
|
2001 |
2018 |
insulinoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
258
|
8
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
53 |
|
2002 |
2020 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
32 |
|
2002 |
2020 |
Mammary Carcinoma, Animal
|
disease |
Neoplasms; Animal Diseases
|
Neoplastic Process
|
144
|
|
0.300 |
None |
1.000 |
5 |
|
2002 |
2010 |
Hematopoietic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
322
|
2
|
0.050 |
None |
0.800 |
5 |
|
2002 |
2019 |
Lymphoma, T-Cell, Cutaneous
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
367
|
5
|
0.050 |
None |
0.800 |
5 |
|
2002 |
2016 |
Animal Mammary Neoplasms
|
phenotype |
Neoplasms; Animal Diseases
|
Neoplastic Process
|
147
|
|
0.300 |
None |
1.000 |
5 |
|
2002 |
2010 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2019 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.310 |
None |
1.000 |
4 |
|
2002 |
2013 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.500 |
None |
1.000 |
4 |
|
2002 |
2007 |
Anaplastic carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
232
|
3
|
0.300 |
None |
1.000 |
3 |
|
2002 |
2007 |
Undifferentiated carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
283
|
8
|
0.300 |
None |
1.000 |
3 |
|
2002 |
2007 |
Carcinomatosis
|
phenotype |
Neoplasms
|
Neoplastic Process
|
186
|
2
|
0.300 |
None |
1.000 |
3 |
|
2002 |
2007 |
Hodgkin Disease
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
900
|
148
|
0.030 |
None |
1.000 |
3 |
|
2002 |
2017 |
Carcinoma, Spindle-Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
218
|
5
|
0.300 |
None |
1.000 |
3 |
|
2002 |
2007 |
Malignant transformation
|
phenotype |
|
Neoplastic Process
|
1027
|
20
|
0.030 |
None |
1.000 |
3 |
|
2002 |
2019 |
Malignant Head and Neck Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
767
|
118
|
0.020 |
None |
1.000 |
2 |
|
2002 |
2004 |
Oestrogen receptor positive breast cancer
|
disease |
|
Neoplastic Process
|
510
|
58
|
0.020 |
None |
1.000 |
2 |
|
2002 |
2006 |
Severe Combined Immunodeficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
284
|
46
|
0.020 |
None |
0.500 |
2 |
|
2002 |
2020 |